Method and apparatus for augumenting bone defects

Information

  • Patent Grant
  • 9289299
  • Patent Number
    9,289,299
  • Date Filed
    Friday, March 15, 2013
    11 years ago
  • Date Issued
    Tuesday, March 22, 2016
    8 years ago
Abstract
A bone augment for repairing a bone defect and associated method. The bone augment includes a porous body and a reinforcement member. The porous body defines a plurality of pores and is configured to be intraoperatively shaped to correspond to the bone defect. The reinforcement member is mounted on an exterior surface of the porous body and is configured to be intraoperatively shaped to correspond to the bone defect.
Description
FIELD

The present disclosure relates to methods and apparatus for augmenting bone defects.


BACKGROUND

This section provides background information related to the present disclosure and is not necessarily prior art.


Bone damage and/or bone loss can occur, for example, due to disease, trauma, and/or birth defects. Bone implants or augments can be used to repair such damaged bone. Bone augments are often manufactured from metal and have a permanent shape and size, thereby providing only limited restoration of bone stock. A bone augment that can be completely remodeled into bone over time and be modified intraoperatively would be desirable.


SUMMARY

This section provides a general summary of the disclosure, and is not a comprehensive disclosure of its full scope or all of its features.


The present teachings provide for a bone augment for repairing a bone defect. The bone augment includes a porous body and a metallic liner. The porous body defines a bore and is configured to be intraoperatively shaped to correspond to the bone defect. The metallic liner is injection molded within the bore such that portions of the liner interlock with pores of the porous body. The metallic liner is operable to mount an implant to the bone augment.


The present teachings also provide for a bone augment for repairing a bone defect that includes a porous body and a metallic liner. The porous body defines a bore and is configured to be intraoperatively shaped to correspond to the bone defect. The metallic liner is secured within the bore.


The present teachings also provide for a bone augment for repairing a bone defect that includes a bone engaging body and an exterior surface. The bone engaging body defines a plurality of pores. The body is configured to be intraoperatively shaped to correspond to the bone defect. An exterior surface of the bone engaging body includes a polymeric reinforcement member mounted thereto. The reinforcement member is operable to be intraoperatively shaped to correspond to the bone defect.


Further areas of applicability will become apparent from the description provided herein. The description and specific examples in this summary are intended for purposes of illustration only and are not intended to limit the scope of the present disclosure.





DRAWINGS

The drawings described herein are for illustrative purposes only of selected embodiments and not all possible implementations, and are not intended to limit the scope of the present disclosure.



FIG. 1A is a perspective view of a bone augment according to the present teachings prior to being shaped to correspond to a particular bone defect;



FIG. 1B is a perspective view of the bone augment of FIG. 1A after being shaped to correspond to a particular bone defect;



FIG. 2 is a cross-sectional view of the bone augment of FIG. 1B taken along line 2-2 and showing pores of the bone augment filled with a polymeric material;



FIG. 3 is a cross-sectional view of the bone augment of FIG. 1B with the pores of the bone augment filled with a metallic material;



FIG. 4 is a cross-sectional view of the bone augment of FIG. 1B with a metallic sleeve mounted within a bore of the bone augment;



FIG. 5 is a cross-sectional view of the bone augment of FIG. 1B with a metallic insert mounted within the bore of the bone augment;



FIG. 5A is a top view of the bone augment of FIG. 5;



FIG. 5B illustrates the detail at area 5B of FIG. 5;



FIG. 5C illustrates an additional arrangement of the detail found at area 5B of FIG. 5;



FIG. 5D illustrates another arrangement of the detail found at area 5B of FIG. 5;



FIG. 5E is a cross-sectional view of the bone augment of FIG. 1B with an additional metallic insert mounted within the bore of the bone augment;



FIG. 6 is a cross-sectional view of the bone augment of FIG. 1B with a taper base mounted within the bore of the bone augment;



FIG. 7 is a cross-sectional view of a bone augment according to an additional aspect of the present teachings, the bone augment including a reinforcement member mounted thereto;



FIG. 8 is a side view of the bone augment of FIG. 1 being intraoperatively shaped to fit a bone defect;



FIG. 9 is a cross-sectional view of the bone augment of FIG. 5 seated within a defect site of a femur to support a femoral implant;



FIG. 10 is a cross-sectional view of the bone augment of FIG. 6 mounted within a defect site of a femur to support a femoral stem implant and a femoral head implant;



FIG. 11A is a perspective view of the bone augment of FIG. 7 being implanted in a defect site of a tibia bone;



FIG. 11B is a perspective view of the bone augment of FIG. 7 implanted within the defect site of the tibia bone; and



FIG. 12 is a top view of the bone augment of FIG. 7 implanted within the defect site of the tibia bone.





Corresponding reference numerals indicate corresponding parts throughout the several views of the drawings.


DETAILED DESCRIPTION

Example embodiments will now be described more fully with reference to the accompanying drawings.


A bone augment according to the present teachings is illustrated in FIGS. 1A-3 at reference numeral 10. The augment 10 includes a body 11 having a biocompatible construct that defines a plurality of pores 12, that can include a strengthening component 14. The augment 10 can be intraoperatively shaped as desired to fill a bone defect of most any size or shape, such as a defect in cancellous bone. The augment 10 can include a density similar to that of cancellous bone.


The augment 10 can be made of any suitable porous material, such as a ceramic or coral, which can be remodeled to bone. Suitable corals include coral hydrothermically converted to hydroxyapatite, such as any of the Pro Osteon® family of bone augments by Biomet of Warsaw, Ind., including Pro Osteon® 200R and 500R for example, which have pore sizes of about 200 and 500 microns respectively. Pro Osteon® is offered in various shapes and sizes, such as a square or rectangular block, as illustrated in FIG. 1A. Using a suitable cutting device, such as a scalpel, saw, or rongeurs, a block of Pro Osteon® can be shaped intraoperatively in any suitable manner, such as to provide a wedge-shaped augment 10 illustrated in FIG. 1B, in order to fill a bone defect of most any shape or size. Pro Osteon® is further described in U.S. Pat. No. 3,929,971 (issued Dec. 30, 1975 to Roy) and U.S. Pat. No. 4,976,736 (issued Dec. 11, 1990 to White et al.), which are hereby incorporated by reference. The porous construct of the augment 10 provides a matrix for new bone ingrowth to facilitate healing.


As illustrated in FIGS. 2 and 3, the augment 10 can include the strengthening component 14 within the pores 12 to enhance the mechanical strength of the augment 10. The strengthening component 14 can be inserted in the augment 10 in any suitable manner, such as by being injected into the pores 12. The strengthening component 14 can be provided such that it fills all of the pores 12, or only a portion of the pores 12. Upon implantation at a defect site, the body 11 resorbs and bone grows into voids previously occupied by the body 11, as well as into any of the pores 12 left unoccupied by the strengthening component.


The strengthening component 14 can include any suitable biocompatible component, such as a suitable polymer or non-metal 14A (FIG. 2), or a suitable metal 14B (FIG. 3). Suitable polymers and non-metals include one or more of the following: ultra-high molecular weight polyethylene, pyrocarbon, silicone, polyether ether ketone (“PEEK”), carbon fiber reinforced PEEK (such as PEEK-OPTIMA® from Invibio, Ltd. of the United Kingdom), and/or vitamin E stabilized highly crosslinked polyethylene (HXLPE), such as described in U.S. Pat. No. 7,431,874 and all continuation applications and patents related thereto, which are incorporated herein by reference. An exemplary vitamin E stabilized HXLPE that may be used includes E-Poly™ offered by Biomet Orthopedics, Inc. of Warsaw, Ind. Suitable metals include, for example, CoCr, titanium, and combinations thereof. Use of the strengthening component 14 is optional.


With additional reference to FIG. 4, the body 11 of the augment 10 can define a bore 16 extending partially or entirely there through. The bore 16 can have any suitable size or shape. For example, the bore 16 can be tapered along its length as illustrated and have a size sufficient to accommodate a stem of a femoral implant therein. The bore 16 can be formed using any suitable cutting device, such as a suitable drill or mill.


The bore 16 can include any suitable liner operable to provide a mechanical connection with an implant, such as a femoral implant stem. The liner increases the strength of the augment 10 to facilitate support of the implant and prevent the augment from possibly fracturing. As illustrated in FIG. 4, the liner can include a tapered metallic sleeve 18 that is metal injection molded into the bore 16 to provide the metallic sleeve 18 with a unitary structure. During the injection molding process, portions of the metallic material enter the pores 12. Upon cooling, the metallic material provides a mechanical interlock with the pores 12 proximate to the bore 16. The tapered sleeve 18 provides a tapered connection with the stem of a femoral implant seated therein, such as a Morse taper lock.


With additional reference to FIGS. 5 and 5A, the liner can include a modular metallic insert 20. The insert 20 includes a main body 22 and a cap 24. The main body 22 includes a first flange 26 and the cap 24 includes a second flange 28. The main body 22 and the cap 24 are positioned in the bore 16 such that the first flange 26 and the second flange 28 are proximate an exterior surface 30 of the augment 10. To accommodate the first flange 26 and the second flange 28, a portion of the exterior surface 30 can be cut out using a suitable cutting device, such as a scalpel, knife, or rongeurs, to permit the first flange 26 and the second flange 28 to be positioned coplanar with the exterior surface 30. In the alternative, the portion of the exterior surface 30 that is cut out can be made in a manufacturing environment, such as with a mill. The first flange 26 and the second flange 28 can also be positioned such that they protrude slightly beyond the exterior surface 30.


The first flange 26 and the second flange 28 can be annular flanges or have any suitable shape to restrict rotation of the insert 20 within the bore 16, such as triangular, square, or hexagonal. The shape of the flanges 26 and 28 can be independent of the shape of the bore 16. For example, FIG. 5A illustrates the first flange 26 having a triangular shape and the main body 22 of the insert 20 having a cylindrical shape. A suitable adhesive can also be provided between the insert 20 and the portion of the body 11 defining the bore 16 to restrict rotation of the insert 20 and retain the insert 20 within the bore 16. Absent the insert 20, friction between the insert 20 and the portion of the body 11 defining the bore 16 can also assist in retaining the insert 20 within the bore 16 and restrict rotation of the insert 20.


As illustrated in FIGS. 5 and 5B, the cap 24 includes a tab 31 that is configured to mate with a recess 33 at an exterior surface of the insert 20 to secure the cap 24 to the main body 22. Thus, after the main body 22 is inserted in the bore 16, the cap 24 is mounted thereto by snapping the tab 31 into the recess 33. The tab 31 and the recess 33 can be annular or there can be multiple tabs 31 and recesses 33 spaced about the cap 24 and main body 22 respectively. Further, the illustrated configuration can be reversed such that the tab 31 can be provided on the main body 22 and the recess 33 is provided in the cap 24.


The cap 24 can be mounted to the main body 22 in any suitable manner. For example and with reference to FIG. 5C, the cap 24 can be welded to the main body 22 using a suitable welding device. Further, and with additional reference to FIG. 5D, the main body can include threads 35 that cooperate with threads 39 to allow the cap 24 to be screwed into engagement with the main body 22. Also and with reference to FIG. 5E, the main body 22 can be provided with a first elongated tapered outer surface 41 and the cap 24 can be provided with a stem 43 having a second elongated tapered outer surface 45. The first tapered surface 41 and the second tapered surface 45 are angled such that a Morse taper lock is formed therebetween when the surfaces 41 and 45 are pressed together.


With additional reference to FIG. 6, the liner can include a taper base 32 having a first taper 34 and a second taper 36 with a support portion 37 therebetween to provide additional strength and support to the insert 20. The first taper 34 is of any suitable size or shape to provide a Morse taper connection with a suitable implant component, such as a femoral neck for supporting a femoral head. The second taper 36 is of any suitable size or shape to provide a Morse taper connection with another suitable implant component, such as a femoral stem. While the taper base 32 is illustrated as including taper connections 34 and 36, the taper base 32 can include any other suitable attachment feature in place of, or in addition to, the taper connections 34 and 36.


The taper base 32 includes a flange 38 at an end thereof that abuts the exterior surface 30 of the augment 10 when the taper base 32 is seated within the bore 16. A cap 40 interlocks with the taper base 32 in any suitable manner, such as through a snap-fit connection between a tab 42 extending from the cap 40 and a recess 47 in the taper base 32. Further, any of the other connection mechanisms described herein can be used, such as those described in FIGS. 5B-5E.


The cap 40 includes a flange 44 that abuts the exterior surface of the augment 10 to secure the taper base 32 within the bore 16 to restrict axial movement of the taper base 32 within the bore 16. The flanges 38 and 44 are positioned proximate to the exterior surface 30 of the augment 10. To accommodate the flanges 38 and 44, a portion of the exterior surface 30 can be cut out using a suitable cutting device, such as a scalpel, knife, or rongeurs, to permit the flanges 38 and 44 to be positioned coplanar with the exterior surface 30. In the alternative, the portion of the exterior surface 30 that is cut out can be made in a manufacturing environment, such as with a mill. The flanges 38 and 44 can also be positioned such that they protrude slightly beyond the exterior surface 30. The flanges 38 and 44 can be annular flanges or have any suitable shape to restrict rotation of the taper base 32 within the bore 16, such as triangular similar to the shape of the flange 26 of FIG. 5A, square, or hexagonal.


With additional reference to FIG. 7, another augment according to the present teachings is illustrated at reference numeral 50. The augment 50 can include the same materials and composition as described herein with respect to the augment 10. Thus, the description of the materials and composition of the augment 10 also serves as a description of the augment 50 and need not be repeated. Like the augment 10, the augment 50 includes a body that defines a plurality of pores. The body and pores of the augment 50 are similar to the body 11 pores 12 of the augment 10 and thus are designated with the reference numerals 11′ and 12′ respectively. The body 11′ can replace cancellous bone, as described below.


The augment 50 also includes a reinforcement member 52. The reinforcement member 52 includes a first projection 54 and a second projection 56, each projection 54 and 56 includes an aperture 58 capable of receiving a suitable fastening device, such as a screw 60. The reinforcement member 52 can replace cortical bone, as described further below, and includes a density similar to cortical bone. The reinforcement member 52 can include any suitable biocompatible material, such as one or more metallic or polymeric materials.


Suitable polymers or non-metals include one or more of the following: ultra-high molecular weight polyethylene, pyrocarbon, silicone, polyether ether ketone (“PEEK”), carbon fiber reinforced PEEK (such as PEEK-OPTIMA® from Invibio, Ltd. of the United Kingdom), and/or vitamin E stabilized highly crosslinked polyethylene (HXLPE), such as described in U.S. Pat. No. 7,431,874 and all continuation applications and patents related thereto, which are incorporated herein by reference. An exemplary vitamin E stabilized HXLPE that may be used includes E-Poly or E1™ offered by Biomet of Warsaw, Ind. Suitable metals include, for example, CoCr, titanium, and combinations thereof.


The projections 54 and 56 can be deformed in any suitable manner to match the morphology of a repair site. For example, the projections 54 and 56 can be bent with a suitable instrument (such as pliers or a roll bender, for example), can be pressed into a mold of the implant site, and can be machined during manufacturing to correspond a specific patient's morphology.


The reinforcement member 52 can be mounted to the augment 50 in any suitable matter, such as with injection molding or compression molding. With both injection molding and compression molding, portions of the reinforcement member 52 enter a portion of the pores 12′ to provide a mechanical interlock with the pores 12′. As with the augment 50, the reinforcement member 52 can be machined in order to fit a particular defect site. As further discussed herein, the augment with the reinforcement member 52 mounted thereto can be used to fill an uncontained defect, such as at a peripheral portion of a tibia upper extremity, because the reinforcement member 52 can retain the augment 50 in an uncontained defect through cooperation between the screws 60 and surrounding bone.


As illustrated in FIG. 8, the augment 50 can be intraoperatively shaped to accommodate a defect. Both the body 11′ and the reinforcement member 52 can be shaped. To shape the body 11′, a cutting device 104, such as a scalpel, saw, or rongeurs, for example, can be used. To shape the reinforcement member 52, a bur, saw, or rongeurs, for example, can be used.


With additional reference to FIG. 9, use of the porous augment 10 in a proximal portion of a femur 100 to fill a defect 102 during a femoral joint replacement is illustrated. The augment 10 includes the bore 16 and the insert 20 mounted therein. The bore 16 is formed therein with a suitable cutting device, such as a suitable drill or mill.


To shape the body 11, a suitable cutting device, such as a scalpel, saw, or rongeurs, for example, can be used. The shaped augment 10 is secured at the defect site 102 in any suitable manner, such as with a press-fit or suitable fastener, to fill damaged cancellous bone. The composition of the augment 10, particularly Pro Osteon®, permits insertion of a fastener into the augment 10 without pre-drilling. Any suitable implant, such as a femoral implant 106 having a stem 108 and a neck 110 supporting a head 111, can be attached to the augment 10 for support. As illustrated, the stem 108 is inserted into the bore 16 to mate with the metallic insert 20, which secures the stem 108 with a press-fit and/or a Morse taper. During the healing process bone grows into the pores 12 of the augment 10 and the augment 10 is remodeled into the femur 100, except for the metallic insert 20.


The insert 20 is optional. When the insert 20 is not used, the stem 108, or any suitable implant, can be secured within the bore 16 with a suitable fastening device or material, such as poly methyl methacrylate (“PMMA”) bone cement.


With additional reference to FIG. 10, implantation of the augment 10 including the taper base 32 is illustrated. As described previously, the augment 10 is intraoperatively shaped to fill the defect 102 and then secured in the defect 102 in any suitable manner, such as with a press-fit or suitable fastener, to fill damaged cancellous bone. The second taper 36 of the taper base 32 is mounted to a suitable implant, such as a femoral stem implant 120. A taper connection surface 122 of the stem implant 120 is mated with the second taper 36 of the taper base 32 to secure the femoral stem implant 120 to the taper base 32 with a Morse taper. A femoral neck implant 124 having a taper connection 126 is mounted to the taper base 32 through cooperation between the taper connection 126 and the first taper 34 of the taper base 32. During healing the augment 10 is remodeled into the femur 100, except for the taper base 32. As illustrated, the taper connection surface 122 provides the male end of the Morse taper and the second taper 36 provides the female end, but this configuration can be reversed.


With reference to FIGS. 11A, 11B, and 12, use of the porous augment 50 at an upper extremity of a tibia 150 to fill a defect 152 is illustrated. The augment 50 includes the reinforcement member 52 mounted thereto.


The augment 50 and reinforcement member 52 can each be intraoperatively shaped to accommodate the uncontained defect 152 using a suitable cutting device. To shape the body 11′ the cutting device 104, such as a scalpel, saw, or rongeurs, for example, can be used. To shape the reinforcement member 52, a bur, saw, or rongeurs, for example, can be used. The shaped augment 50 is secured at the defect site 152 with the screws 60, which extend through the projections 54 and 56 and into an area of the tibia 150 proximate to the defect 152 having bone of sufficient rigidity to retain the screws 60, such as cortical bone. During the healing process, cancellous bone is permitted to grow into the pores 12′ of the augment 50 and the augment 50 is remodeled into the tibia 150, except for the polymeric reinforcement member 52, the rigidity of which serves to replace the missing cortical bone. Thus, the augment 50 is positioned such that the body 11′ provides a bone engaging surface and the reinforcement 52 provides a exterior surface.


Use of the augments 10 and 50 in the femur 100 and the tibia 150 is for exemplary purposes only. The bone augments 10 and 50 can be used to repair any suitable defect in suitable bone. To accommodate use of the augments 10 and 50 in bones of various different sizes, various sized augments 10 and 50 can be provided.


The foregoing description of the embodiments has been provided for purposes of illustration and description. It is not intended to be exhaustive or to limit the invention. Individual elements or features of a particular embodiment are generally not limited to that particular embodiment, but, where applicable, are interchangeable and can be used in a selected embodiment, even if not specifically shown or described. The same may also be varied in many ways. Such variations are not to be regarded as a departure from the invention, and all such modifications are intended to be included within the scope of the invention.

Claims
  • 1. A bone augment for repairing a bone defect present in a single bone comprising: a bone-engaging body defining a plurality of pores, the body configured to be intraoperatively shaped to correspond to the bone defect present in the single bone; anda polymeric reinforcement member having an inner surface and an outer surface, the inner surface having a first part and a second part, wherein the first part of the inner surface of the polymeric reinforcement member is mounted on an exterior surface of the bone-engaging body, the second part of the inner surface of the reinforcement member is configured to be in contact with an outer bone surface proximate to the bone defect, and the reinforcement member is configured to be intraoperatively deformed to correspond to the bone defect present in the single bone and the outer bone surface proximate to the bone defect;wherein:the first part of the inner surface of the polymeric reinforcement member is molded to the exterior surface such that portions of the reinforcement member are mechanically interlocked with the pores; andthe body includes a density that approximates a density of cancellous bone and the polymeric reinforcement member includes a density that approximates a density of cortical bone.
  • 2. The bone augment of claim 1, the second part further comprising a projection extending from the polymeric reinforcement member, the projection including an aperture configured to receive a fastener to secure the bone augment to bone proximate to the bone defect.
  • 3. The bone augment of claim 1, wherein the body includes at least one of a ceramic and Pro Osteon® and the polymeric reinforcement member includes polyether ether ketone.
  • 4. The bone augment of claim 1, wherein the bone augment is configured to repair an uncontained bone defect with the body replacing cancellous bone and the polymeric reinforcement member replacing cortical bone.
  • 5. The bone augment of claim 1, the second part further comprising first and second projections extending from opposite sides the polymeric reinforcement member, each of the first and second projections including an aperture configured to receive a corresponding fastener to secure the bone augment to the single bone proximate to the bone defect present in the single bone.
  • 6. The bone augment of claim 5, wherein each of the first and second projections is deformable to match the morphology proximate to the bone defect.
  • 7. The bone augment of claim 5, wherein each of the first and second projections can be machined during manufacturing to match a specific patient's morphology.
  • 8. The bone augment of claim 5, wherein each of the first and second projections can be pressed into a mold of a corresponding implant site of a specific patient.
  • 9. The bone augment of claim 1, wherein the reinforcement member is mounted on the body by injection or compression molding.
  • 10. A bone augment for repairing a bone defect comprising: a bone-engaging body defining a plurality of pores, the body configured to be intraoperatively shaped to correspond to the bone defect entirely defined at an upper extremity of a tibia; anda polymeric reinforcement member having an inner surface and an outer surface, the inner surface having a first part and a second part, wherein the first part of the inner surface of the polymeric reinforcement member is mounted on an exterior surface of the bone-engaging body and the second part of the inner surface of the polymeric reinforcement member having first and second extensions corresponding to opposite sides of the defect entirely defined at the upper extremity of the tibia, and the reinforcement member configured to be intraoperatively deformed to correspond to the bone defect entirely defined at the upper extremity of the tibia with the first and second extensions configured to be deformed to correspond to an outer bone surface proximate to the bone defect;wherein:the first part of the inner surface of the polymeric reinforcement member is molded to the exterior surface such that portions of the reinforcement member are mechanically interlocked with the pores; andthe body includes a density that approximates a density of cancellous bone and the polymeric reinforcement member includes a density that approximates a density of cortical bone.
  • 11. The bone augment of claim 10, wherein each of the first and second projections is deformable to match a patient's morphology proximate to the bone defect.
  • 12. The bone augment of claim 10, wherein each of the first and second projections can be machined during manufacturing to match a specific patient's morphology.
  • 13. The bone augment of claim 10, wherein each of the first and second extensions include an aperture configured to receive a corresponding fastener to secure the bone augment to a single bone proximate to the bone defect entirely defined at the upper extremity of the tibia.
  • 14. The bone augment of claim 10, wherein the body includes at least one of a ceramic and Pro Ostean® and the polymeric reinforcement member includes polyether ether ketone.
  • 15. The bone augment of claim 10, wherein the bone augment is configured to repair the bone defect when the bone defect is an uncontained bone defect with the body replacing cancellous bone and the polymeric reinforcement member replacing cortical bone.
  • 16. A method for repairing a bone defect comprising: molding an inner surface of a polymeric reinforcement member to an exterior surface of a porous body at a first part of the inner surface of the polymeric reinforcement member such that portions of the reinforcement member are mechanically interlocked with pores of the porous body;inserting the porous body into a bone defect entirely defined by a single bone, the porous body shaped to correspond to the bone defect entirely defined by the single bone;deforming first and second extensions of a second part of the inner surface of the polymeric reinforcement member of the bone augment to match the inner surface at the second part of the polymeric reinforcement member with an outer surface of the single bone on opposite sides of the bone defect; andfastening the first and second extensions of the second part of the inner surface of the polymeric reinforcement member to the single bone on opposite sides of the bone defect entirely defined by the single bone;wherein the body includes a density that approximates density of cancellous bone and the polymeric reinforcement member includes a density that approximates density of cortical bone.
  • 17. The method of claim 16, further comprising bending the first and second extensions to match a patient morphology of the single bone around the bone defect entirely defined by the single bone.
  • 18. The method of claim 16, wherein the bone augment is configured for a bone defect entirely defined at an upper extremity of a tibia.
  • 19. The method of claim 16, further comprising inserting the porous body into an uncontained bone defect entirely defined by the single bone such that the porous body replaces cancellous bone and the polymeric reinforcement member replaces cortical bone.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a divisional of U.S. application Ser. No. 12/708,309 filed Feb. 18, 2010. The entire disclosure of the above application is incorporated herein by reference.

US Referenced Citations (254)
Number Name Date Kind
3605123 Hahn Sep 1971 A
3929971 Roy Dec 1975 A
4202055 Reiner et al. May 1980 A
4502161 Wall Mar 1985 A
4599086 Doty Jul 1986 A
4655777 Dunn et al. Apr 1987 A
4722870 White Feb 1988 A
4737411 Graves, Jr. et al. Apr 1988 A
4769011 Swaniger Sep 1988 A
4822366 Bolesky Apr 1989 A
4846839 Noiles Jul 1989 A
4861733 White Aug 1989 A
4892545 Day et al. Jan 1990 A
4944757 Martinez et al. Jul 1990 A
4969896 Shors Nov 1990 A
4976736 White et al. Dec 1990 A
5002578 Luman Mar 1991 A
5084051 Tormala et al. Jan 1992 A
5137535 Keller Aug 1992 A
5152791 Hakamatsuka et al. Oct 1992 A
5181928 Bolesky et al. Jan 1993 A
5186162 Talish et al. Feb 1993 A
5211160 Talish et al. May 1993 A
5290313 Heldreth Mar 1994 A
5306311 Stone et al. Apr 1994 A
5348788 White Sep 1994 A
5455100 White Oct 1995 A
5487933 White Jan 1996 A
5552454 Kretschmann et al. Sep 1996 A
5571193 Kampner Nov 1996 A
5607474 Athanasiou et al. Mar 1997 A
5620448 Puddu Apr 1997 A
5653765 McTighe et al. Aug 1997 A
5725592 White et al. Mar 1998 A
5728510 White Mar 1998 A
5766251 Koshino Jun 1998 A
5824088 Kirsch Oct 1998 A
5876452 Athanasiou et al. Mar 1999 A
5876459 Powell Mar 1999 A
5879391 Slamin Mar 1999 A
5879394 Ashby et al. Mar 1999 A
5902340 White et al. May 1999 A
5904717 Brekke et al. May 1999 A
5906644 Powell May 1999 A
5910172 Penenberg Jun 1999 A
5931871 Baur et al. Aug 1999 A
5976188 Dextradeur et al. Nov 1999 A
5977204 Boyan et al. Nov 1999 A
5986169 Gjunter Nov 1999 A
6008430 White Dec 1999 A
6008433 Stone Dec 1999 A
6013853 Athanasiou et al. Jan 2000 A
6066175 Henderson et al. May 2000 A
6080194 Pachence et al. Jun 2000 A
6086593 Bonutti Jul 2000 A
6093205 McLeod et al. Jul 2000 A
6120503 Michelson Sep 2000 A
6156037 LeHuec et al. Dec 2000 A
6156070 Incavo et al. Dec 2000 A
6187329 Agrawal et al. Feb 2001 B1
6200347 Anderson et al. Mar 2001 B1
6203546 MacMahon Mar 2001 B1
6206922 Zdeblick et al. Mar 2001 B1
6224602 Hayes May 2001 B1
6235059 Benezech et al. May 2001 B1
6264698 Lawes et al. Jul 2001 B1
6264699 Noiles et al. Jul 2001 B1
6270502 Stulberg Aug 2001 B1
6296667 Johnson et al. Oct 2001 B1
6302888 Mellinger et al. Oct 2001 B1
6309395 Smith et al. Oct 2001 B1
6319286 Fernandez et al. Nov 2001 B1
6342157 Hood, III Jan 2002 B1
6344496 Niederauer et al. Feb 2002 B1
6350284 Tormala et al. Feb 2002 B1
6364881 Apgar et al. Apr 2002 B1
6365149 Vyakarnam et al. Apr 2002 B2
6376573 White et al. Apr 2002 B1
6383221 Scarborough et al. May 2002 B1
6454811 Sherwood et al. Sep 2002 B1
6464728 Murray Oct 2002 B1
6518328 Kumar Feb 2003 B2
6520994 Nogarin Feb 2003 B2
6524342 Muhlhausler et al. Feb 2003 B1
6524345 Valimaa et al. Feb 2003 B1
6527810 Johnson et al. Mar 2003 B2
6562073 Foley May 2003 B2
6565884 Nimni May 2003 B2
6575982 Bonutti Jun 2003 B1
6576017 Foley et al. Jun 2003 B2
6626945 Simon et al. Sep 2003 B2
6626950 Brown et al. Sep 2003 B2
6632246 Simon et al. Oct 2003 B1
6632247 Boyer, II et al. Oct 2003 B2
6635087 Angelucci et al. Oct 2003 B2
6699252 Farr et al. Mar 2004 B2
6706072 Dwyer et al. Mar 2004 B2
6716250 Ganjianpour Apr 2004 B2
6723129 Dwyer et al. Apr 2004 B2
6843805 Webb et al. Jan 2005 B2
6843808 Grundei Jan 2005 B2
6858042 Nadler et al. Feb 2005 B2
6869450 Grundei Mar 2005 B2
6875239 Gerbec et al. Apr 2005 B2
6887276 Gerbec et al. May 2005 B2
6981991 Ferree Jan 2006 B2
6989034 Hammer et al. Jan 2006 B2
7018420 Grundei Mar 2006 B2
7097664 Despres, III et al. Aug 2006 B2
7105026 Johnson et al. Sep 2006 B2
7122056 Dwyer et al. Oct 2006 B2
7122057 Beam et al. Oct 2006 B2
7156880 Evans et al. Jan 2007 B2
7166133 Evans et al. Jan 2007 B2
7175664 Lakin Feb 2007 B1
7189263 Erbe et al. Mar 2007 B2
7192448 Ferree Mar 2007 B2
7291169 Hodorek Nov 2007 B2
7427293 Nycz et al. Sep 2008 B2
7431874 Muratoglu et al. Oct 2008 B2
7435263 Barnett et al. Oct 2008 B2
7445639 Metzger et al. Nov 2008 B2
7470289 Brehm Dec 2008 B2
7497874 Metzger et al. Mar 2009 B1
7531000 Hodorek May 2009 B2
7572291 Gil et al. Aug 2009 B2
7582092 Jones et al. Sep 2009 B2
7682540 Boyan et al. Mar 2010 B2
7691114 Duche Apr 2010 B1
7691150 Cronin et al. Apr 2010 B2
7740662 Barnett et al. Jun 2010 B2
7758643 Stone et al. Jul 2010 B2
7780708 Morris et al. Aug 2010 B2
7794503 Daniels et al. Sep 2010 B2
7806911 Peckham Oct 2010 B2
7819918 Malaviya et al. Oct 2010 B2
7833245 Kaes et al. Nov 2010 B2
7854737 Daniels et al. Dec 2010 B2
7857858 Justin et al. Dec 2010 B2
7879100 Denoziere et al. Feb 2011 B2
7892261 Bonutti Feb 2011 B2
7892291 Evans et al. Feb 2011 B2
7909883 Sidebotham Mar 2011 B2
7951205 McCleary et al. May 2011 B2
7972380 Linares Jul 2011 B2
8012205 Plouhar et al. Sep 2011 B2
8083749 Taber Dec 2011 B2
8100982 Heck et al. Jan 2012 B2
8133421 Boyce et al. Mar 2012 B2
8142502 Stone et al. Mar 2012 B2
8163028 Metzger et al. Apr 2012 B2
8187326 Hammer et al. May 2012 B2
8231685 Fritz et al. Jul 2012 B2
8241293 Stone et al. Aug 2012 B2
8241367 Justin et al. Aug 2012 B2
8257444 Linares Sep 2012 B2
RE43714 Nadler et al. Oct 2012 E
8323543 Michelson Dec 2012 B2
8444699 Metzger et al. May 2013 B2
8480757 Gage et al. Jul 2013 B2
8592531 Thomas et al. Nov 2013 B2
8641775 Harmon et al. Feb 2014 B2
8652214 Fritz et al. Feb 2014 B2
8753391 Lu et al. Jun 2014 B2
8753392 Melvin et al. Jun 2014 B2
8764830 Robinson et al. Jul 2014 B2
8771353 Gedet et al. Jul 2014 B2
8771363 Grotz Jul 2014 B2
8834568 Shapiro Sep 2014 B2
8864826 Pressacco Oct 2014 B2
20010039455 Simon et al. Nov 2001 A1
20020004685 White Jan 2002 A1
20020029084 Paul et al. Mar 2002 A1
20020065558 Varga et al. May 2002 A1
20020107571 Foley Aug 2002 A1
20020107572 Foley et al. Aug 2002 A1
20020119177 Bowman et al. Aug 2002 A1
20020123750 Eisermann et al. Sep 2002 A1
20020143403 Vaidyanathan et al. Oct 2002 A1
20020183845 Mansmann Dec 2002 A1
20030065397 Hanssen et al. Apr 2003 A1
20030105526 Bryant et al. Jun 2003 A1
20030109878 Grundei Jun 2003 A1
20030125740 Khanna Jul 2003 A1
20030139818 Rogers et al. Jul 2003 A1
20030167092 Foley Sep 2003 A1
20030195632 Foley et al. Oct 2003 A1
20040030388 Null et al. Feb 2004 A1
20040034419 Carter et al. Feb 2004 A1
20040059416 Murray et al. Mar 2004 A1
20040111161 Trieu Jun 2004 A1
20040162619 Blaylock et al. Aug 2004 A1
20040210222 Angelucci et al. Oct 2004 A1
20040243248 Despres et al. Dec 2004 A1
20040254646 Stone et al. Dec 2004 A1
20050010304 Jamali Jan 2005 A1
20050015088 Ringeisen Jan 2005 A1
20050075641 Singhatat et al. Apr 2005 A1
20050090900 Nordquist Apr 2005 A1
20050177245 Leatherbury et al. Aug 2005 A1
20050228498 Andres Oct 2005 A1
20050251268 Truncale Nov 2005 A1
20050278034 Johnson et al. Dec 2005 A1
20060020346 Hunter et al. Jan 2006 A1
20060173550 Ragbir Aug 2006 A1
20060224242 Swords et al. Oct 2006 A1
20060235542 Hodorek et al. Oct 2006 A1
20060241756 Fritz et al. Oct 2006 A1
20060293760 DeDeyne Dec 2006 A1
20070021838 Dugas et al. Jan 2007 A1
20070083268 Teoh et al. Apr 2007 A1
20070088443 Hanssen et al. Apr 2007 A1
20070093834 Stevens et al. Apr 2007 A1
20070135924 Verhoogen Jun 2007 A1
20070179607 Hodorek et al. Aug 2007 A1
20070213830 Ammann et al. Sep 2007 A1
20070233272 Boyce et al. Oct 2007 A1
20080133008 Truncale et al. Jun 2008 A1
20080188945 Boyce et al. Aug 2008 A1
20080195099 Minas Aug 2008 A1
20080249632 Stone et al. Oct 2008 A1
20080262616 McKay Oct 2008 A1
20090043398 Yakimicki et al. Feb 2009 A1
20090082770 Worner et al. Mar 2009 A1
20090149963 Sekel Jun 2009 A1
20090177203 Reiley Jul 2009 A1
20090306787 Crabtree et al. Dec 2009 A1
20100023130 Henry et al. Jan 2010 A1
20100047309 Lu et al. Feb 2010 A1
20100057197 Weber et al. Mar 2010 A1
20100114314 Lomicka et al. May 2010 A1
20100137990 Apatsidis et al. Jun 2010 A1
20100145452 Blaylock et al. Jun 2010 A1
20100241239 Smith Sep 2010 A1
20100292791 Lu et al. Nov 2010 A1
20110012280 Deslauriers et al. Jan 2011 A1
20110040334 Kaes et al. Feb 2011 A1
20110160870 Baumgartner et al. Jun 2011 A1
20110172798 Staiger et al. Jul 2011 A1
20110178604 Porter Jul 2011 A1
20110190887 Shapiro Aug 2011 A1
20110196503 Anapliotis et al. Aug 2011 A1
20110208189 Faccioli et al. Aug 2011 A1
20110213376 Maxson et al. Sep 2011 A1
20110238180 Fritz et al. Sep 2011 A1
20120232596 Ribeiro Sep 2012 A1
20120232656 Gedet et al. Sep 2012 A1
20120323324 Buskirk et al. Dec 2012 A1
20130030528 Chen et al. Jan 2013 A1
20130079877 Buma et al. Mar 2013 A1
20130090732 Duda et al. Apr 2013 A1
20130116788 Schwartz et al. May 2013 A1
20140045967 Thomas et al. Feb 2014 A1
20140172116 Maxson et al. Jun 2014 A1
Non-Patent Literature Citations (6)
Entry
“Artificial Bone Grafts:Pro Osteon”, http://www.arthroscopy.com/sp12013.htm, Copyright 1999, 4 sheets.
Bio-Medicine; Pro Osteon Bone Graft Substitutes (2pgs).
Pro Osteon® 200R Bone Graft Substitute, Medcompare, Copyright 2003-2009, (2pgs).
Pro Osteon® 500R; Biomet, Copyright 2009 (1pg).
Pro Osteon® Biomet 200R (1pg).
The Natural Facts About Pro Osteon Implant 500, Interpore International (6pgs).
Related Publications (1)
Number Date Country
20130211536 A1 Aug 2013 US
Divisions (1)
Number Date Country
Parent 12708309 Feb 2010 US
Child 13834914 US